Lamictal 100mg dispersible tablets

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
27-02-2019
Produkta apraksts Produkta apraksts (SPC)
20-04-2020

Aktīvā sastāvdaļa:

Lamotrigine

Pieejams no:

Mawdsley-Brooks & Company Ltd

ATĶ kods:

N03AX09

SNN (starptautisko nepatentēto nosaukumu):

Lamotrigine

Deva:

100mg

Zāļu forma:

Dispersible tablet

Ievadīšanas:

Oral

Klase:

No Controlled Drug Status

Receptes veids:

Valid as a prescribable product

Produktu pārskats:

BNF: 04080100

Lietošanas instrukcija

                                _ _
OTHER SIDE EFFECTS
Other side effects have occurred in a small number of people but
their exact frequency is unknown:

There have been reports of bone disorders including
osteopenia and osteoporosis (thinning of the bone) and
fractures. Check with your doctor or pharmacist if you are on
long-term anti-epileptic medication, have a history of
osteoporosis or take steroids

Nightmares

Lower immunity because of lower levels of antibodies called
immunoglobulins in the blood which help protect against
infection.
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed on this leaflet. You can
also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in
the GOOGLE PLAY or APPLE APP STORE. By reporting side effects,
you can help provide more information on the safety of this
medicine.
5
HOW TO STORE LAMICTAL

KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.

Do not store above 30°C. Store in a dry place. Protect from
light.

Do not use after the expiry date printed on the carton label or
blister strip.

If your doctor tells you to stop using the medicine, please take it
back to the pharmacist for safe disposal. Only keep the
medicine if your doctor tells you to.

If the medicine becomes discoloured or shows any other signs
of deterioration, you should seek the advice of your pharmacist
who will tell you what to do.

If you have any unwanted Lamictal tablets, don’t dispose of
them in your waste water or your household rubbish. Take them
back to your pharmacist, who will dispose of them in a way that
won’t harm the environment.
6
CONTENTS OF THE PACK AND OTHER INFORMATION
WHAT LAMICTAL CONTAINS

Each 100mg dispersible tablet contains 100mg lamotrigine.

Lamictal Dispersible also contain the following inactive
ingredients: calcium carbonate, low substituted
hydroxypropylcellulose, aluminium magnesium silicate, sodium
starch glycollate, pov
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Not applicable
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Not applicable
3.
PHARMACEUTICAL FORM
Not applicable
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Not applicable
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Not applicable
4.3.
CONTRAINDICATIONS
Not applicable
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not applicable
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Not applicable
4.6.
PREGNANCY AND LACTATION
Not applicable
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8.
UNDESIRABLE EFFECTS
Not applicable
4.9.
OVERDOSE
Not applicable
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC PROPERTIES
Not applicable
5.2.
PHARMACOKINETIC PROPERTIES
Not applicable
5.3.
PRECLINICAL SAFETY DATA
Not applicable
6.
PHARMACEUTICAL PARTICULARS
6.1.
LIST OF EXCIPIENTS
Not applicable
6.2.
INCOMPATIBILITIES
Not applicable
6.3.
SHELF LIFE
Not applicable
6.4.
SPECIAL PRECAUTIONS FOR STORAGE
Not applicable
6.5.
NATURE AND CONTENTS OF CONTAINER
Not applicable
6.6.
INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL)
Not applicable
No Data Held
ADMINISTRATIVE DATA
7.
Marketing Authorisation Holder
Not applicable
8.
MARKETING AUTHORISATION NUMBER
Not applicable
9.
DATE OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION
Not applicable
10.
DATE OF (PARTIAL) REVISION OF TEXT
Not applicable
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu